Request a copy of the file
Enter the following information to request a copy for the following item: Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more : results of a multicenter phase 3 study.
Requesting the following file: LowenbergBetalBlood2010.pdf